Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. III. Biological properties.
- 1 January 1989
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 42 (5) , 674-679
- https://doi.org/10.7164/antibiotics.42.674
Abstract
Mureidomycins (MRD''s) A .apprx. D were specifically active against Pseudomonas aeruginosa. Among them, MRD C was most active, with MICs of 0.1 to 3.13 .mu.g/ml against many strains of the target organism. Its activity was comparable to that of cefoperazone, ceftazidime and cefsulodin. MRD C-resistant mutants of P. aeruginosa appeared spontaneously at a high frequency when cultued in the presence of the antibiotic. No cross-resistance was observed with .beta.-lactam antibiotics. A rapid decrease of turbidity along with spheroplast formation and cell lysis was observed when cells of P. aeruginoasa were grown in the presence of MRD C. The coumpounds exhibited low toxicity and protected mice from experimental infection with P. aeruginosa. The urinary and fecal recoveries of MRD C given subcutaneously were 5 and 18%, respectively.This publication has 2 references indexed in Scilit:
- Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. II. Structural elucidation.The Journal of Antibiotics, 1989
- Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. I. Taxonomy, fermentation, isolation and physico-chemical properties.The Journal of Antibiotics, 1989